Consolidated Statement of Changes in Equity - USD ($) $ in Millions |
Total |
Issued capital [member] |
Share premium [member] |
Treasury shares [member] |
Reserves [member] |
OCI reserves [member] |
Retained earnings [member] |
Equity attributable to owners of parent [member] |
Non-controlling interest [member] |
|---|---|---|---|---|---|---|---|---|---|
| Beginning balance at Dec. 31, 2022 | $ 84,278 | $ 1,736 | $ 17,620 | $ (3,706) | $ 54,477 | $ (35,553) | $ 38,823 | $ 73,398 | $ 10,880 |
| Profit of the period | 6,891 | 5,341 | 5,341 | 1,550 | |||||
| Other comprehensive income/(loss) | 3,876 | 4,398 | 4,398 | (522) | |||||
| Total comprehensive income (loss) | 10,767 | 4,398 | 5,341 | 9,739 | 1,028 | ||||
| Dividends | (2,952) | (1,582) | (1,582) | (1,371) | |||||
| Treasury shares | (237) | 240 | (477) | (237) | |||||
| Share-based payments | 438 | 418 | 418 | 19 | |||||
| Hyperinflation monetary adjustments | 675 | 417 | 417 | 258 | |||||
| Scope and other changes | (291) | (306) | (306) | 15 | |||||
| Ending balance at Dec. 31, 2023 | 92,676 | 1,736 | 17,620 | (3,465) | 54,896 | (31,155) | 42,215 | 81,848 | 10,828 |
| Profit of the period | 7,416 | 5,855 | 5,855 | 1,561 | |||||
| Other comprehensive income/(loss) | (8,812) | (8,046) | (8,046) | (766) | |||||
| Total comprehensive income (loss) | (1,396) | (8,046) | 5,855 | (2,191) | 795 | ||||
| Dividends | (3,178) | (1,764) | (1,764) | (1,414) | |||||
| Treasury shares | (791) | (421) | (370) | (791) | |||||
| Share-based payments | 515 | 495 | 495 | 20 | |||||
| Hyperinflation monetary adjustments | 1,040 | 642 | 642 | 398 | |||||
| Scope and other changes | (166) | (1) | (1) | (165) | |||||
| Ending balance at Dec. 31, 2024 | 88,700 | 1,736 | 17,620 | (3,886) | 55,391 | (39,201) | 46,577 | 78,237 | 10,463 |
| Profit of the period | 8,477 | 6,837 | 6,837 | 1,640 | |||||
| Other comprehensive income/(loss) | 6,726 | 6,560 | 6,560 | 166 | |||||
| Total comprehensive income (loss) | 15,203 | 6,560 | 6,837 | 13,397 | 1,806 | ||||
| Dividends | (4,286) | (2,466) | (2,466) | (1,820) | |||||
| Treasury shares | (2,106) | (1,197) | (910) | (2,106) | |||||
| Share-based payments | 135 | 136 | 136 | (1) | |||||
| Hyperinflation monetary adjustments | 429 | 265 | 265 | 164 | |||||
| Scope and other changes | (339) | (176) | (176) | (163) | |||||
| Ending balance at Dec. 31, 2025 | $ 97,736 | $ 1,736 | $ 17,620 | $ (5,083) | $ 55,526 | $ (32,641) | $ 50,128 | $ 87,287 | $ 10,449 |
| X | ||||||||||
- Definition Increase (decrease) through hyperinflation adjustments No definition available.
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of dividends recognised as distributions to owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of residual interest in the assets of the entity after deducting all its liabilities. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from share-based payment transactions. [Refer: Equity] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from changes that the entity does not separately disclose in the same statement or note. [Refer: Equity] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The increase (decrease) in equity resulting from treasury share transactions. [Refer: Equity; Treasury shares] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- References Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The total of income less expenses from continuing and discontinued operations, excluding the components of other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|